Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
ANHEUSER BUSCH INBEV SA NV (BUD)
NYSEConsumer StaplesBeverages - AlcoholicSnapshot 2026-11-04
$85.20+1.83%
Close 2026-11-05 · 1-day change
NYSEConsumer StaplesBeverages - AlcoholicSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
4.98 → 4.91 EPS · FY ending Dec 31, 2027 · 10 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 9 to 10; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BUD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Free cash flow generation | Profit margins are expected to remain strong, supporting cash flow generation. | Intact | free cash flow falls below 9 billion USD | Free cash flow: $3.839B FY2026-Q2; GAAP. Published target: >=11 billion USD. Annual target cannot be compared with a quarterly or TTM observation. Jul 30, 20263,838,771,350 USD · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
BUD is a consumer-staples business with a sector tailwind, but the evidence is too limited to classify it confidently as a durable compounder or another investment type. The current thesis state is insufficient because there is not enough recent financial-performance history.
The snapshot provides no valuation measure or clear account of market expectations, so whether BUD looks cheap, fair, or expensive versus peers cannot be assessed. Fragility is rated low, with no identified fragility gates.
Near term, the reported miss risk is low, but BUD has a run of consecutive earnings misses and missed its most recent quarter. Over the multi-year view, the evidence does not establish a clear fundamental trajectory; the sector backdrop is supportive, while weakening jobs data could increase recession concerns.
The near-term sector signal depends partly on whether bellwethers DEO, STZ, and TAP continue to beat earnings and guide higher, or begin missing and guiding lower. A further swing factor is whether jobs data continues weakening, which could weigh more heavily on cyclical names.
For the next one to three years, the thesis is unresolved: sector momentum is a support, but repeated earnings misses and limited performance history leave execution unclear. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in ANHEUSER BUSCH INBEV SA NV's published investment case. The stated target is >=15%. |
| Intact |
| profit margin falls below 13% |
Net margin: 19.78% FY2026-Q2; GAAP. Published target: >=15%. Annual target cannot be compared with a quarterly or TTM observation. Jul 30, 202619.776365 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth for FY26 | A primary condition in ANHEUSER BUSCH INBEV SA NV's published investment case. The stated target is >=65 billion USD. | Intact | revenue falls below 63 billion USD for FY26 | Revenue: $31.927B FY2026-Q2; GAAP. Published target: >=65 billion USD. Annual target cannot be compared with a quarterly or TTM observation. Jul 30, 202631,927,000,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.93 → $4.91 · observed estimates
$67.43B → $67.29B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-27 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-08-28 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-08-29 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-08-30 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-08-31 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-01 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-02 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-03 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-04 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-05 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-06 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-07 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-08 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-09 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-10 | $4.93 | $67,431,924,235 | 9 / 16 |
| 2026-09-11 | $4.93 | $67,450,817,873 | 9 / 16 |
| 2026-09-12 | $4.93 | $67,479,136,054 | 9 / 16 |
| 2026-09-13 | $4.93 | $67,479,136,054 | 9 / 16 |
| 2026-09-14 | $4.93 | $67,479,136,054 | 9 / 16 |
| 2026-09-15 | $4.94 | $67,510,720,233 | 9 / 16 |
| 2026-09-16 | $4.94 | $67,510,744,014 | 9 / 16 |
| 2026-09-17 | $4.94 | $67,543,648,776 | 9 / 16 |
| 2026-09-18 | $4.94 | $67,543,648,776 | 9 / 16 |
| 2026-09-19 | $4.94 | $67,543,648,776 | 9 / 16 |
| 2026-09-20 | $4.95 | $67,559,206,613 | 9 / 16 |
| 2026-09-21 | $4.95 | $67,559,206,613 | 9 / 16 |
| 2026-09-22 | $4.95 | $67,559,206,613 | 9 / 16 |
| 2026-09-23 | $4.95 | $67,559,206,613 | 9 / 16 |
| 2026-09-24 | $4.95 | $67,559,206,613 | 9 / 16 |
| 2026-09-25 | $4.99 | $67,596,149,013 | 9 / 16 |
| 2026-09-26 | $4.99 | $67,596,144,252 | 9 / 16 |
| 2026-09-27 | $4.99 | $67,596,144,252 | 9 / 16 |
| 2026-09-28 | $4.99 | $67,596,144,252 | 9 / 16 |
| 2026-09-29 | $4.98 | $67,470,390,187 | 9 / 16 |
| 2026-09-30 | $4.98 | $67,469,818,757 | 9 / 16 |
| 2026-10-01 | $4.98 | $67,469,818,757 | 9 / 16 |
| 2026-10-02 | $4.98 | $67,469,818,757 | 9 / 16 |
| 2026-10-03 | $4.98 | $67,469,818,757 | 9 / 16 |
| 2026-10-04 | $4.98 | $67,469,818,757 | 9 / 16 |
| 2026-10-05 | $4.98 | $67,469,818,757 | 9 / 16 |
| 2026-10-06 | $4.98 | $67,469,818,757 | 9 / 16 |
| 2026-10-07 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-08 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-09 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-10 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-11 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-12 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-13 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-14 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-15 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-16 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-17 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-18 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-19 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-20 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-21 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-22 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-23 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-24 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-25 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-26 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-27 | $4.98 | $67,469,818,757 | 10 / 16 |
| 2026-10-28 | $4.91 | $67,287,687,822 | 10 / 16 |
| 2026-10-29 | $4.91 | $67,287,687,822 | 10 / 16 |
| 2026-10-30 | $4.91 | $67,287,687,822 | 10 / 16 |
| 2026-10-31 | $4.91 | $67,287,687,822 | 10 / 16 |
| 2026-11-01 | $4.91 | $67,287,687,822 | 10 / 16 |
| 2026-11-02 | $4.91 | $67,287,687,822 | 10 / 16 |
| 2026-11-03 | $4.91 | $67,287,687,822 | 10 / 16 |
| 2026-11-04 | $4.91 | $67,287,687,822 | 10 / 16 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 10 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.